Cencora Inc vs Henry Schein Inc

Cencora Inc (COR) is slightly overvalued and Henry Schein Inc (HSIC) is overvalued.

Both trade above our estimate of their intrinsic value. COR is the closer of the two: -20%, against -48% for HSIC.

Values as of the 22 Sept 2026 close.

Cencora Inc (COR)

Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $262.24; the price of $314.43 is 20% above that value, and 80% of that value comes from beyond year five.

Leak Score 57/100 on 10 of 12 signals

Henry Schein Inc (HSIC)

Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $58.94; the price of $87.43 is 48% above that value, and 79% of that value comes from beyond year five.

Leak Score 14/100 on 3 of 12 signals

MetricCORHSIC
VerdictSlightly overvaluedOvervalued
Price$314.43$87.43
Intrinsic value$262.24$58.94
Margin of safety-20%-48%
Leak Score57/100 (10/12)14/100 (3/12)
Market cap$60.0B$9.7B
Revenue growth, 5 years11.1%5.4%
Operating margin1.3%6.0%
Net margin0.8%3.0%
Return on equity104.3%12.2%
Debt to equity3.841.21
P/E23.4x25.5x
Forward P/E15.9x14.6x
P/B19.7x3.1x
Dividend yield0.8%

All stocks in Medical Distribution